LIGHTPOINT
Desconocido
CerISMA: Cerenkov Imaging for Surgical Margin Assessment
LIGHTPOINT MEDICAL LTD
tramitó un
H2020:
H2020-SMEInst-2014-2015
Cancer is not only a leading public health challenge in Europe, it is also a growing economic challenge. Over three million cases are curren...
2015-11-24 - 2019-06-30 | Financiado
2015-11-24 - 2019-06-30 | Financiado
CLI: The CLIO consortium Optimization of Cerenkov Luminescence Imaging for Image Guided Cancer Surgery
LIGHTPOINT MEDICAL LTD
participó en un
FP7:
Cancer is the second largest cause of death and morbidity in Europe, with more than 3 million new cases diagnosed each year. The most effect...
Financiado
Financiado
* No se disponen de datos de la empresa actual.